| Product Name | Eliglustat enantiomer |
| Product Code | DA-E028-02 |
| Chemical name | N-[(1S,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide |
| Synonyms | N-((1S,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)octanamide; |
| Impurity | NA |
| CAS Number | 1092472-70-2 |
| Alternate CAS # | NA |
| Molecular form | C23H36N2O4 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 404.55 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | impurities,metabolites,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | N-[(1S,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide is the stereoisomer of N-[(1R,2R)-2-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide or Eliglustat which is a treatment for Gaucher disease. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
